2月5日,嘉事堂药业股份有限公司(以下简称嘉事堂)发布详式权益变动报告书,披露权益变动最新进展。根据报告书,中国北京同仁堂(集团)有限责任公司(以下简称同仁堂集团)拟以14.61亿元的价格收购嘉事堂28.48%的股份。交易完成后,同仁堂集团将成为嘉事堂第一大股东,延伸布局医药流通领域,进一步完善大健康产业链条。报告书显示,2月2日,嘉事堂股东中国光大医疗健康产业有限公司(以下简称光大健康)、中国...
Source Link2月5日,嘉事堂药业股份有限公司(以下简称嘉事堂)发布详式权益变动报告书,披露权益变动最新进展。根据报告书,中国北京同仁堂(集团)有限责任公司(以下简称同仁堂集团)拟以14.61亿元的价格收购嘉事堂28.48%的股份。交易完成后,同仁堂集团将成为嘉事堂第一大股东,延伸布局医药流通领域,进一步完善大健康产业链条。报告书显示,2月2日,嘉事堂股东中国光大医疗健康产业有限公司(以下简称光大健康)、中国...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.